Member Info for sonicboomboy

Jave a feeling this is going on a constant trend now.

810p then 1023p

https://twitter.com/ukbambammatt/status/1314106302570942464

Sharehnter, you might be right.

That's my initial baseline and I will not be selling a single share until that point - at the earliest.

That gives us entry into Mid Tier status and we know that's where GM is aiming at and believes we will get to.

As others have said though this can all change very quickly and I expect my forecasts to be revised upwards significantly the next few months.

Big contracts are sure to land and Covid isn't going anywhere. If countires lockdown then the world has a serious reason to ramp up testing to drag things back on track. If they get us out there and to keep the economy afloat, they will need to ramp up testing even more.

Its a total win win if you are invested in NCYT IMO.

https://twitter.com/ukbambammatt/status/1313835821267595269

I wouldnt worry about one share signs.

Think total reality. Pennant forming on the chart. Care Homes Trial Results and huge order coming soon, alongside a huge French order.

Pennant well formed and will be looking to breakout to the UPSIDE. Pennants are continuation patterns of the longer term trend.
https://twitter.com/ukbambammatt/status/1313744487517229056
GLA

.....keep your eyes open for another one over the next day or two.

Dojo star on the 30m looks like a failed breakout attempt. Currently that is. Still watching though.

...moving higher into close. Bodes well for a strong start again tomorrow

Based on what we already know, let alone what else is coming along.

https://twitter.com/ukbambammatt/status/1311933940521984004

Wilson,

I readi it somewhere at the time , cant remembee if it was here or on Telegram.

Maybe someone else can verify.

Did I hear correctly that from the AGM there had been another order come in on the day or the AGM?
I assume its fairly significant or it wouldn't have been mentioned.

Just seen the RNS.

Well I did think the had been an dramatically increased presence on here, twitter and telegram of new names claiming to be buying shares recently and dragging others in to pump things a bit prior to the inevitable news of the past couple of days.

I'm sure any of us long term holders knew the signs. I have bought a few today on the drop for the first time in years and will keep some powder dry to use over the coming months.

As always patience required...hoping for some movement in the first half of next year on the SP with LC can actually sign some real off but one thing is for sure, I'm not expecting it to be within the next few weeks as RNSd today.

GLA

Sorry to read today's news, looks like hard days ahead until LC can get this over the line. More bluff and bluster from the great man. Fear this will fall away over the coming sessions and weeks as the market judges LC by results and the need for more cash.

GLA LTH

https://twitter.com/ukbambammatt/status/1311250776568877058
https://twitter.com/ukbambammatt/status/1311250293007544320

Baseline figure is 15 quid a share and Mid Cap status at 1 billion pounds. No doubt about it given the potential size of this 1 deal of 800m pounds this is almost a certainty.

UK Contract could be worth 850m plus.

The French contract if rumoured to be true works out roughly the same.

That's 1.7 Billion worth of GBP contract on two orders.

Seriously....1Billion MCAP is 15GBP SP. Obviously this is going alot, lot higher.

UK Contract could be worth 850m plus.

The French contract if rumoured to be true works out roughly the same.

1.7

This first phase of the contract will involve the immediate deployment of 300 PCR instruments, related kits and support services with a minimum value of £150 million for the first 14 weeks. Based on this initial period, a further £100 million of revenue could be expected for the subsequent 10 weeks, however volumes can be varied up or down subject to certain notice criteria given by the DHSC.



The second phase of the contract, which is optional by the DHSC, allows for the provision of up to 700 additional PCR instruments, related kits and support services, as well as additional COVID-19 products from the Company's portfolio where required. Depending upon the uptake, phase two of the contract could generate considerably more sales than the first phase.